{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Self-Expanding TAVR vs Surgery; Ticagrelor vs Prasugrel in PCI; New Guidelines for Treatment of Acute Pulmonary Embolism","description":" In this week\u2019s View, Dr. Eagle\u202flooks at findings from the Evolut Low Risk trial in which self-expanding transcatheter aortic valve replacement (TAVR) versus surgery at six years in low-risk patients with aortic stenosis (AS) is considered. He then\u202fexplores\u202fthe\u202fTUXEDO-2 Trial evaluating ticagrelor versus prasugrel in percutaneous coronary intervention patients with diabetes and multivessel coronary disease (MVD). Finally,\u202fDr. Eagle examines\u202fthe first-ever release of the AHA\/ACC guideline for treatment and management of acute pulmonary embolism (PE) in adults.   \u202fSubscribe to Eagle\u2019s Eye View\u202f\u202f  ","author_name":"Eagle's Eye View: Your Weekly CV Update From ACC.org","author_url":"http:\/\/www.acc.org","html":"